|
OB/GYN Annual Subject
Index 2002
[ Subject
| Author ]
Abortion
Use of misoprostol in obstetric practice. Jun:27-35
back to top
Alternative medicine
Essential fatty acids. Feb:35-41
Herbal products. Dec:34-38
Premenstrual syndrome, pt 1. May:47-49,59
Premenstrual syndrome, pt 2. Jul:38-40
The use of an isoflavone supplement to relieve hot flushes. Aug:35-37
Vasomotor symptom control. Nov(suppl):9-14
back to top
Autoimmune disorders
Contemporary management of human immunodeficiency virus during pregnancy. Jul:10-16
Management of asthma in pregnancy. Jun:16-26
Multiple sclerosis, pt 1. Sep:24-27
Multiple sclerosis, pt 2. Oct:24-34
Recognizing and treating nonallergic rhinitis. Aug:20-32
Unusual presentation of sarcoidosis. Jul:28-30
back to top
Back disorders
Chronic noncancer pain. Jan:21-26
back to top
Breast-feeding
Epilepsy in the female patient. Mar:32-39
Psychotropic medications, pt 2: use during lactation. Jan:27-38
back to top
Cancer
Advances in ovarian cancer. Feb(suppl):22-26
Breast cancer and sexuality. May:51-52
Breast mass management. Feb(suppl):6
Chemotherapy-induced peripheral neuropathy. Feb(suppl):27-30
Clinical trials. Feb(suppl):3-5
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:9-10,56
Critical issues in menopause. Dec(CME suppl):1-2
Current and future directions in breast cancer care. Mar(suppl):13-19
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
Hereditary breast cancer. Sep:31-36
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Hormone replacement and cancer. Jun(suppl):13-19
The Human Genome Project and women’s health. Jul:31-32
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Metastatic breast cancer. Feb(suppl):18-21
Neoadjuvant chemotherapy. Feb(suppl):12-17
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 1. Jun:11-15
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 2. Jul:21-27
Small call ovarian carcinoma. Jan:13-15
Summarizing the evidence. Nov(suppl):32-34
The TCH study. Feb(suppl):7-11
Vaginal reconstruction. Sep:38-43
back to top
Cardiovascular
disorders
Cardiovascular disease. Mar(suppl):20-26
Cardiovascular disease. Aug:48-49
Cardiovascular disease [algorithm]. Nov(suppl):19
Cardiovascular disease in women. Jun(suppl):25-29
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:9-10,56
Critical issues in menopause. Dec(CME suppl):1-2
Estrogen and atherosclerosis. Dec(CME suppl):2-4
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Low-dose ERT/HRT. Jan:42-43
Summarizing the evidence. Nov(suppl):32-34
back to top
Continuing Medical
Education (CME)
Abdominal hysterectomy. Aug:15-19
Abnormal uterine bleeding. Feb:15-21
Chronic noncancer pain. Jan:21-26
Chronic pelvic pain [test]. May(suppl):23-24
Contemporary management of human immunodeficiency virus during pregnancy. Jul:10-16
Continuous use of oral contraceptives [test]. Apr(suppl):23-24
Effective use of nonsteroidal anti-inflammatory drugs. Nov:25-33
Epilepsy and reproductive health [test]. Sep(suppl):35-36
HRT and SERMs [test]. Mar(suppl):39-40
Multiple sclerosis, pt 1. Sep:24-27
Obstetric anal sphincter lacerations, pt 1. Apr:21-24
Obstetric anal sphincter lacerations, pt 2. May:31-36
Obstetric embolic disease. Mar:12-14
Postmenopausal health care [test]. Nov(suppl):35-36
Putting WHI into perspective [test]. Dec(CME suppl):8
Raloxifene versus standard hormone replacement. Jun:36-40
Strategic options for cancer care [test]. Feb(suppl):31-32
Surgical treatment of genuine stress urinary incontinence, pt 1. Oct:11-15
von Willebrand disease and menorrhagia. Dec:15-19
back to top
Contraception and
contraceptives
Benefits beyond contraception. Dec(suppl):12-18
Clinician-patient counseling. Dec(suppl):30-32
Combination OCs and prescribed antibiotics. Mar:40-41
Continuous OC use. Dec:49-50
Continuous oral contraceptive use. Apr(suppl):3
Contraceptive efficacy and body weight. Oct:36-38
DMPA: has it been a decade already? May:57-59
Drospirenone. Apr:45-49
An evolving state. Dec(suppl):19-24
Fair access to contraception. Mar:10-11
Family planning. Sep(suppl):31-34
Managing patients using the transdermal contraceptive system. Aug(suppl):26-32
Meeting today’s contraceptive needs. Aug(suppl):3
Patterns in contraception. Dec(suppl):8-11
A planned production. Jan:40-41
Rationale for new contraceptive methods. Aug(suppl):4-13
Substantial progress in contraception. Feb:10
Successful oral contraceptive use. Dec(suppl):2
Therapeutic options. Apr(suppl):12-16
Therapeutic substitution of low-dose OCs. Mar:15-16
Three new formulations. Dec(suppl):25-29
The transdermal contraceptive system. Aug(suppl):14-25
Unintended pregnancy. Dec(suppl):3-7
Words from our faculty. Apr(suppl):17-22
back to top
Dermatologic
disorders
Adding laser procedures to physicians’ practices.
Jan:39
Common skin problems in older women. Jun(suppl):35-38
back to top
Diabetes
A planned production. Jan:40-41
back to top
Diet
Essential fatty acids. Feb:35-41
back to top
Editorials
Don’t just complain…write! Sep:11-12
Fair access to contraception. Mar:10-11
FDA device approval. Apr:13-14
Liability insurance. Aug:8
Medical practice: using the right model. Jul:9
The need for evidence-based medicine. Nov(suppl):3
A new era–an old problem. Jun:6
The patient from another country. Oct:7-8
Patient trust and evidence-based medicine. Nov:11-12
The poor economy will affect us, too. Dec:7
Random thoughts for the New Year. Jan:8-10
Something’s gotta give. May:10
Substantial progress in contraception. Feb:10
back to top
Endocrinologic
disorders
Thyroid disease in pregnancy. Apr:31-36
Thyroid disorders. Jun(suppl):30-34
back to top
Exercise
Exercise and bone health. Jun:49-50
back to top
Gastrointestinal
disorders
Effective use of nonsteroidal anti-inflammatory drugs.
Nov:25-33
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
Obstetric anal sphincter lacerations, pt 1. Apr:21-2
Obstetric anal sphincter lacerations, pt 2. May:31-36
back to top
Genetics
Cracking genetic code will transform medicine. Feb:42-45
Cystic fibrosis screening in current practice. Apr:25-28
First-trimester ultrasonographic screening for aneuploidy. Sep:13-18
Genetic screening. Nov:44,54
Hereditary breast cancer. Sep:31-36
The Human Genome Project and women’s health. Jul:31-32
New-onset clitoromegaly associated with Alport syndrome. Nov:52-54
New opportunities in prenatal diagnosis: practical benefits from the Human
Genome Project. Sep:51-53
Recurrent first-trimester pregnancy loss. Dec:39-48
Screening for Down syndrome. Feb:22-30
back to top
Gynecologic disorders
Abdominal hysterectomy. Aug:15-19
Abnormal uterine bleeding. Feb:15-21
Advances in ovarian cancer. Feb(suppl):22-26
Benefits beyond contraception. Dec(suppl):12-18
Breast cancer and sexuality. May:51-52
Breast mass management. Feb(suppl):6
Chemotherapy-induced peripheral neuropathy. Feb(suppl):27-30
Chronic noncancer pain. Jan:21-26
Chronic pelvic pain of bladder origin. May(suppl):3
Clinical trials. Feb(suppl):3-5
Continuous oral contraceptive use. Apr(suppl):3
Critical issues in menopause. Dec(CME suppl):1-2
Current and future directions in breast cancer care. Mar(suppl):13-19
Diagnosis and management of long-term complications of uterine artery embolization.
Nov:13-24
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
Hereditary breast cancer. Sep:31-36
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Hormone replacement and cancer. Jun(suppl):13-19
Images in women’s health. Oct:39-40; Nov:50-51; Dec:53-54
Interstitial cystitis presenting as endometriosis. May(suppl):12-13
Keeping her healthy. Jun(suppl):11
Metastatic breast cancer. Feb(suppl):18-21
The need for evidence-based medicine. Nov(suppl):3
Neoadjuvant chemotherapy. Feb(suppl):12-17
A new era–an old problem. Jun:6
New-onset clitoromegaly associated with Alport syndrome. Nov:52-54
Osteoporosis [algorithm]. Nov(suppl):18
An overview of menstruation. Apr(suppl):4-7
Premenstrual syndrome, pt 1. May:47-49,59
Premenstrual syndrome, pt 2. Jul:38-40
Prevention of symptom progression. May(suppl):4-6
Recurrent posterior vaginal wall abscess. Jan:16
Regulating menstruation. Apr(suppl):8-11
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 1. Jun:11-15
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 2. Jul:21-27
SERMs in preventive health care. Nov(suppl):15-16,20-24
Small call ovarian carcinoma. Jan:13-15
Summarizing the evidence. Nov(suppl):32-34
The TCH study. Feb(suppl):7-11
Therapeutic options. Apr(suppl):12-16
Three case studies in advanced disease. Nov(suppl):25-28
Tools for diagnosis and treatment. May(suppl):12-17,25
Underlying neuropathology of interstitial cystitis. May(suppl):7-11
Unusual presentation of sarcoidosis. Jul:28-30
Uterine leiomyomas and infertility. Dec:26-33
Vaginal reconstruction. Sep:38-43
Vasomotor symptom control. Nov(suppl):9-14
von Willebrand disease and menorrhagia. Dec:15-19
Vulvar vestibulitis and sexual pain. Apr:51-53
Women’s issues in epilepsy. Sep(suppl):3
Words from our faculty. Apr(suppl):17-22
back to top
Headache
Chronic noncancer pain. Jan:21-26
Headaches in the perimenopause. Apr:55-56
back to top
Hematologic disorders
Factor V Leiden mutation, venous thromboembolism, and consideration
of hormone therapy. Nov:55-56
Obstetric embolic disease. Mar:12-14
von Willebrand disease and menorrhagia. Dec:15-19
back to top
Hormones and
hormone therapy
Cardiovascular disease. Mar(suppl):20-26
Cardiovascular disease [algorithm]. Nov(suppl):19
Cardiovascular disease in woman. Jun(suppl):25-29
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:9-10,56
Common skin problems in older women. Jun(suppl):35-38
Continuous oral contraceptive use. Apr(suppl):3
Critical issues in menopause. Dec(CME suppl):1-2
Current and future directions in breast cancer care. Mar(suppl):13-19
Estrogen and atherosclerosis. Dec(CME suppl):2-4
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
Factor V Leiden mutation, venous thromboembolism, and consideration of hormone
therapy. Nov:55-56
The faculty speaks: a roundtable discussion on postmenopausal health care.
Mar(suppl):32-38
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
Hormone effects on seizures. Sep(suppl):15-16,21
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Low-dose ERT/HRT. Jan:42-43
The need for evidence-based medicine. Nov(suppl):3
Osteoporosis. Mar(suppl):5-12
Osteoporosis [algorithm]. Nov(suppl):18
An overview of menstruation. Apr(suppl):4-7
Periodontal disease and the female patient. Oct:19-23
Raloxifene versus standard hormone replacement. Jun:36-40
Regulating menstruation. Apr(suppl):8-11
The role of HRT and SERMs. Mar(suppl):3-4
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
SERMs in preventive health care. Nov(suppl):15-16,20-24
Summarizing the evidence. Nov(suppl):32-34
Therapeutic options. Apr(suppl):12-1
Three case studies in advanced disease. Nov(suppl):25-28
Thyroid disorders. Jun(suppl):30-34
Vasomotor symptom control. Nov(suppl):9-14
Words from our faculty. Apr(suppl):17-22
back to top
Infections
Combination OCs and prescribed antibiotics. Mar:40-41
Contemporary management of human immunodeficiency virus during pregnancy. Jul:10-16
Recurrent posterior vaginal wall abscess. Jan:16
back to top
Infertility
Fertility, reproduction, and epilepsy. Sep(suppl):27-30
Recurrent first-trimester pregnancy loss. Dec:39-48
Uterine leiomyomas and infertility. Dec:26-33
back to top
Laparoscopy
FDA device approval. Apr:13-14
back to top
Laser therapy
The cutting edge: laser hair removal. Mar:42
Laser vein removal. Jun:52
back to top
Menopause
Cardiovascular disease. Mar(suppl):20-26
Cardiovascular disease. Aug:48-49
Cardiovascular disease [algorithm]. Nov(suppl):19
Cardiovascular disease in woman. Jun(suppl):25-29
Cognitive function and menopause. Feb:46-47
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:9-10,56
Common skin problems in older women. Jun(suppl):35-38
Critical issues in menopause. Dec(CME suppl):1-2
Current and future directions in breast cancer care. Mar(suppl):13-19
Estrogen and atherosclerosis. Dec(CME suppl):2-4
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
Exercise and bone health. Jun:49-50
Factor V Leiden mutation, venous thromboembolism, and consideration of hormone
therapy. Nov:55-56
The faculty speaks: a roundtable discussion on postmenopausal health care.
Mar(suppl):32-38
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
Headaches in the perimenopause. Apr:55-56
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Hormone replacement and cancer. Jun(suppl):13-19
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Keeping her healthy. Jun(suppl):11
Low-dose ERT/HRT. Jan:42-43
The need for evidence-based medicine. Nov(suppl):3
Osteoporosis. Mar(suppl):5-12
Osteoporosis [algorithm]. Nov(suppl):18
Periodontal disease and the female patient. Oct:19-23
Queen of rings. Oct:35
Raloxifene versus standard hormone replacement. Jun:36-40
The role of HRT and SERMs. Mar(suppl):3-4
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
SERMs in preventive health care. Nov(suppl):15-16,20-24
Sexual dialogue. Jan:44-45
Summarizing the evidence. Nov(suppl):32-34
Three case studies in advanced disease. Nov(suppl):25-28
Thyroid disorders. Jun(suppl):30-34
The use of an isoflavone supplement to relieve hot flushes. Aug:35-37
Vasomotor symptom control. Nov(suppl):9-14
back to top
Musculoskeletal
disorders
Chronic noncancer pain. Jan:21-26
Effective use of nonsteroidal anti-inflammatory drugs. Nov:25-33
back to top
Neurologic disorders
Chronic noncancer pain. Jan:21-26
Epilepsy and antiepileptic interventions. Sep(suppl):4-9
Epilepsy in the female patient. Mar:32-39
Family planning. Sep(suppl):31-34
Fertility, reproduction, and epilepsy. Sep(suppl):27-30
Fetal outcomes following antiepileptic drug use. Sep(suppl):10-14
Hormone effects on seizures. Sep(suppl):15-16,21
Management of epilepsy in women of childbearing potential [algorithm]. Sep(suppl):18-19
Multiple sclerosis, pt 1. Sep:24-27
Multiple sclerosis, pt 2. Oct:24-34
Prenatal diagnosis and obstetric management. Sep(suppl):22-26
Underlying neuropathology of interstitial cystitis. May(suppl):7-11
Women’s issues in epilepsy. Sep(suppl):3
back to top
Obesity
Contraceptive efficacy and body weight. Oct:36-38
back to top
Obstetrics and
gynecology
Adding laser procedures to physicians’ practices. Jan:39
Don’t just complain…write! Sep:11-12
Liability insurance. Aug:8
Medical practice: using the right model. Jul:9
The patient from another country. Oct:7-8
Patient trust and evidence-based medicine. Nov:11-12
The poor economy will affect us, too. Dec:7
Random thoughts for the New Year. Jan:8-10
Something’s gotta give. May:10
back to top
Osteoporosis
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:9-10,56
Critical issues in menopause. Dec(CME suppl):1-2
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
Exercise and bone health. Jun:49-50
Low-dose ERT/HRT. Jan:42-43
Osteoporosis. Mar(suppl):5-12
Osteoporosis [algorithm]. Nov(suppl):18
Periodontal disease and the female patient. Oct:19-23
Raloxifene versus standard hormone replacement. Jun:36-40
The role of HRT and SERMs. Mar(suppl):3-4
SERMs in preventive health care. Nov(suppl):15-16,20-24
Summarizing the evidence. Nov(suppl):32-34
Three case studies in advanced disease. Nov(suppl):25-28
back to top
Pain
Chronic pelvic pain of bladder origin. May(suppl):3
Effective use of nonsteroidal anti-inflammatory drugs. Nov:25-33
Interstitial cystitis presenting as endometriosis. May(suppl):12-13
Intetstitial cystitis presenting as overactive bladder. May(suppl):13-14
Interstitial cystitis presenting as recurrent urinary tract infection and vulvodynia.
May(suppl):21-22
Tools for diagnosis and treatment. May(suppl):12-17,25
Underlying neuropathology of interstitial cystitis. May(suppl):7-11
back to top
Patient education
All about antibiotics. S32:9-11
Becoming an effective advocate for better epilepsy care. Sep(suppl):17,20
The best care you can give. S33:22-24
A cancer treatment guide. S33:12-16
Caregivers need care, too. S37:9-10
Combination hormone replacement therapy and the Women’s Health Initiative.
S36:7-8
Could you have diabetes and not know it? S37:3-5
On the cutting edge of breast cancer research. S33:17-19
Defend yourself against cancer. S33:2-7
Do you have a sexually transmitted disease? S32:15-16
Eating with irritable bowel syndrome. S37:15-17
Educating patients about generic medications. Sep:44-50
The feminine face of epilepsy. S32:5-8
Getting a grip on tonsillitis. S35:5-6
How we manage pain. S32:1-4
I stopped smoking, and you can, too! S34:6-7
Increase your iron intake. S32:17
Is alternative medicine right for you? S33:20-21
A kava kava caveat. S35:16-17
Making scents of our sexuality. S36:15-16
Melanoma. S34:12-13
Menopause and cancer awareness. S34:8-10
Menopause and urinary problems. S35:11-12
Milestones in breast cancer care. S33:8-11
Morning-after options for contraceptive slips. S35:13-14
New insights in fibromyalgia. S36:12-14
Preparing for natural menopause. S32:13-14
Re-examining sexual desire. S37:13-14
Save calories on fast food. S36:17
Stamp out food-borne illness. S36:9-11
Thyroid disease & genetics. S35:1-4
Turning setbacks into comebacks. S36:3-6
Understanding acne. S37:6-8
Understanding period-free contraception. S35:7-10
Understanding recent postmenopausal health care. Nov(suppl):17
Up and at ‘em! S34:11
What every woman should know about osteoporosis. S37:11-12
Your heart is in your hands. S34:1-5
Your orgasm. S34:16-17
Zap away unwanted hair. S34:15
back to top
Pharmacotherapy
Advances in ovarian cancer. Feb(suppl):22-26
Breast mass management. Feb(suppl):6
Chemotherapy-induced peripheral neuropathy. Feb(suppl):27-30
Chronic noncancer pain. Jan:21-26
Clinical trials. Feb(suppl):3-5
Combination OCs and prescribed antibiotics. Mar:40-41
Current and future directions in breast cancer care. Mar(suppl):13-19
Educating patients about generic medications. Sep:44-50
Effective use of nonsteroidal anti-inflammatory drugs. Nov:25-33
Epilepsy and antiepileptic interventions. Sep(suppl):4-9
Epilepsy in the female patient. Mar:32-39
Family planning. Sep(suppl):31-34
Fertility, reproduction, and epilepsy. Sep(suppl):27-30
Fetal outcomes following antiepileptic drug use. Sep(suppl):10-14
Herbal products. Dec:34-38
Management of asthma in pregnancy. Jun:16-26
Management of epilepsy in women of childbearing potential [algorithm]. Sep(suppl):18-19
Metastatic breast cancer. Feb(suppl):18-21
Neoadjuvant chemotherapy. Feb(suppl):12-17
Prenatal diagnosis and obstetric management. Sep(suppl):22-26
Psychotropic medications, pt 2: use during lactation. Jan:27-38
Small call ovarian carcinoma. Jan:13-15
The TCH study. Feb(suppl):7-11
Therapeutic substitution of low-dose OCs. Mar:15-16
back to top
Pregnancy
Bereavement in multiple birth, pt 1. Mar:19-25
Bereavement in multiple birth, pt 2. Apr:39-42
Broad-based conversion to elective cesarean delivery is not justified. May:19,25-28
Contemporary management of human immunodeficiency virus during pregnancy. Jul:10-16
Cystic fibrosis screening in current practice. Apr:25-28
Epilepsy in the female patient. Mar:32-39
Fertility, reproduction, and epilepsy. Sep(suppl):27-30
Fetal demise from food poisoning. Jul:41
Fetal outcomes following antiepileptic drug use. Sep(suppl):10-14
First-trimester ultrasonographic screening for aneuploidy. Sep:13-18
Large condylomata acuminata in pregnancy. Aug:41-43
Management of asthma in pregnancy. Jun:16-26
Management of epilepsy in women of childbearing potential [algorithm]. Sep(suppl):18-19
Multiple pregnancy. Mar:26-30
New opportunities in prenatal diagnosis: practical benefits from the Human
Genome Project. Sep:51-53
Obstetric anal sphincter lacerations, pt 1. Apr:21-24
Obstetric anal sphincter lacerations, pt 2. May:31-36
Obstetric embolic disease. Mar:12-14
Periodontal disease and the female patient. Oct:19-23
A planned production. Jan:40-41
Prenatal diagnosis and obstetric management. Sep(suppl):22-26
Prophylactic benefits of elective cesarean delivery. May:18,20-24,28
Recurrent first-trimester pregnancy loss. Dec:39-48
Thyroid disease in pregnancy. Apr:31-36
Unintended pregnancy. Dec(suppl):3-7
Use of misoprostol in obstetric practice. Jun:27-35
back to top
Prenatal screening
Bereavement in multiple birth, pt 1. Mar:19-25
Bereavement in multiple birth, pt 2. Apr:39-42
Broad-based conversion to elective cesarean delivery is not justified. May:19,25-28
Contemporary management of human immunodeficiency virus during pregnancy. Jul:10-16
Cystic fibrosis screening in current practice. Apr:25-28
Fetal outcomes following antiepileptic drug use. Sep(suppl):10-14
First-trimester ultrasonographic screening for aneuploidy. Sep:13-18
Genetic screening. Nov:44,54
Large condylomata acuminata in pregnancy. Aug:41-43
Management of asthma in pregnancy. Jun:16-26
Management of epilepsy in women of childbearing potential [algorithm]. Sep(suppl):18-19
Multiple pregnancy. Mar:26-30
New opportunities in prenatal diagnosis: practical benefits from the Human
Genome Project. Sep:51-53
Obstetric embolic disease. Mar:12-14
Prenatal diagnosis and obstetric management. Sep(suppl):22-26
Prophylactic benefits of elective cesarean delivery. May:18,20-24,28
Recurrent first-trimester pregnancy loss. Dec:39-48
Screening for Down syndrome. Feb:22-30
Thyroid disease in pregnancy. Apr:31-36
back to top
Preventive medicine
Cardiovascular disease [algorithm]. Nov(suppl):19
A planned production. Jan:40-41
SERMs in preventive health care. Nov(suppl):15-16,20-24
back to top
Psychiatric disorders
Bereavement in multiple birth, pt 1. Mar:19-25
Bereavement in multiple birth, pt 2. Apr:39-42
Chronic noncancer pain. Jan:21-26
Hypoactive sexual desire. Jun:45-46
Listening. Apr:54
Premenstrual syndrome, pt 1. May:47-49,59
Premenstrual syndrome, pt 2. Jul:38-40
Psychotropic medications, pt 2: use during lactation. Jan:27-38
back to top
Pulmonary disorders
Cystic fibrosis screening in current practice. Apr:25-28
Management of asthma in pregnancy. Jun:16-26
back to top
Quiz
Be heart healthy. S32:12
Get the skinny on dining out! S35:15
Nutrition fact…or fiction? S34:14
What you should know about…
Breast self-examination. Oct:45-46
Cesarean section. May:55-56
"Designer" estrogens. Jun:53-54
Diabetes. Mar:47-48
Epilepsy. Feb:49-50
Hormone replacement therapy. Apr:57-58
Hysterectomy. Sep:57-58
Irritable bowel syndrome. Jul:45-46
Medication use while breast-feeding. Jan:47-48
Periodontal disease. Dec:57-58
Sleep and aging. Jun(suppl):39-40
Stress incontinence. Nov:59-60
Your runny nose. Aug:53-54
back to top
Sexuality
Breast cancer and sexuality. May:51-52
Enhancing female orgasm. Mar:43-44
Hypoactive sexual desire. Jun:45-46
Re-examining sexual desire. Oct:41-42
Sexual dialogue. Jan:44-45
Vulvar vestibulitis and sexual pain. Apr:51-53
Women’s sexual pleasure and satisfaction. Aug:44-47
Sexually transmitted diseases (STDs)
Contemporary management of human immunodeficiency virus during pregnancy. Jul:10-16
Large condylomata acuminata in pregnancy. Aug:41-43
back to top
Surgery
Abdominal hysterectomy. Aug:15-19
Adding laser procedures to physicians’ practices. Jan:39
Broad-based conversion to elective cesarean delivery is not justified. May:19,25-28
Diagnosis and management of long-term complications of uterine artery embolization.
Nov:13-24
FDA device approval. Apr:13-14
Laser vein removal. Jun:52
A new era_an old problem. Jun:6
Obstetric anal sphincter lacerations, pt 1. Apr:21-24
Obstetric anal sphincter lacerations, pt 2. May:31-36
Prophylactic benefits of elective cesarean delivery. May:18,20-24,28
Recurrent posterior vaginal wall abscess. Jan:16
Small call ovarian carcinoma. Jan:13-15
Suburethral sling complications. May:37-46
Surgery for genuine stress urinary incontinence, pt 2. Nov:37-43
Surgical treatment of genuine stress urinary incontinence, pt 1. Oct:11-15
Vaginal reconstruction. Sep:38-43
back to top
Ultrasonography
First-trimester ultrasonographic screening for aneuploidy. Sep:13-18
Images in women’s health. Oct:39-40; Nov:50-51; Dec:53-54
back to top
Urologic disorders
Chronic pelvic pain of bladder origin. May(suppl):3
Interstitial cystitis presenting as endometriosis. May(suppl):12-13
Intetstitial cystitis presenting as overactive bladder. May(suppl):13-14
Interstitial cystitis presenting as recurrent urinary tract infection and vulvodynia.
May(suppl):21-22
New-onset clitoromegaly associated with Alport syndrome. Nov:52-54
Prevention of symptom progression. May(suppl):4-6
Suburethral sling complications. May:37-46
Surgery for genuine stress urinary incontinence, pt 2. Nov:37-43
Surgical treatment of genuine stress urinary incontinence, pt 1. Oct:11-15
Tools for diagnosis and treatment. May(suppl):12-17,25
Underlying neuropathology of interstitial cystitis. May(suppl):7-11
back to top
Vitamins and
supplements
Essential fatty acids. Feb:35-41
The use of an isoflavone supplement to relieve hot flushes. Aug:35-37
back to top
|
